Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Pfizer, Inc.
Pfizer shares declined 4.47 percent on volume of over 70.0 million shares traded Tuesday to close at $29.07 a share. Increased generic competition for the company’s cholesterol drug Lipitor saw revenues for the first quarter of 2013 fall 9 percent year-over-year to $13.5 billion.
Going forward ... (see research report)
Subscribe to News Feeds